Neuca SA 

zł760
48
+zł0+0% Monday 18:11

Statistics

Day High
760
Day Low
760
52W High
760
52W Low
760
Volume
34
Avg. Volume
-
Mkt Cap
3.45B
P/E Ratio
0.22
Dividend Yield
2.11%
Dividend
16

Upcoming

Dividends

2.11%Dividend Yield
Jul 25
zł16
Jun 24
zł14.5
Jul 23
zł13
May 22
zł11.5
May 21
zł10
10Y Growth
12.33%
5Y Growth
9.86%
3Y Growth
7.17%
1Y Growth
N/A

Earnings

21MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

1.22%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
25.22BRevenue
308.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0MJR.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including prevention, diagnostics, treatment, and complementary services; and financing services, such as insurance, subscriptions, occupational medicine, preventive and medicine programmes, FFS, NFZ, public, private, and corporate payer services. In addition, the company offers TPA services, remote consultations, in person visits, diagnostic tests, and occupational medicine services; operates a medical helpline and medical facilities; and offers medicine through apteline.pl, an e-commerce medical ordering site. Further, it engages in running clinical trials in the field of outsourcing clinical research and conducting clinical research centres; provision of insurance products, including health insurance products. Additionally, the company provides advertising and marketing services to pharmaceutical market entities; and logistics services for pharmaceutical manufacturers. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
Show more...
CEO
Employees
3681
Country
Poland
ISIN
PLTRFRM00018

Listings

0 Comments

Share your thoughts

FAQ

What is Neuca SA stock price today?
The current price of 0MJR.LSE is zł760 PLN — it has increased by +0% in the past 24 hours. Watch Neuca SA stock price performance more closely on the chart.
What is Neuca SA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neuca SA stocks are traded under the ticker 0MJR.LSE.
What is Neuca SA market cap?
Today Neuca SA has the market capitalization of 3.45B
When is the next Neuca SA earnings date?
Neuca SA is going to release the next earnings report on May 21, 2026.
What is Neuca SA revenue for the last year?
Neuca SA revenue for the last year amounts to 25.22B PLN.
What is Neuca SA net income for the last year?
0MJR.LSE net income for the last year is 308.49M PLN.
Does Neuca SA pay dividends?
Yes, 0MJR.LSE dividends are paid annual. The last dividend per share was 16 PLN. As of today, Dividend Yield (FWD)% is 2.11%.
How many employees does Neuca SA have?
As of April 15, 2026, the company has 3,681 employees.
In which sector is Neuca SA located?
Neuca SA operates in the Energy sector.
When did Neuca SA complete a stock split?
Neuca SA has not had any recent stock splits.